DENVER—DaVita announced that it has reached an agreement in principle to settle all claims arising out of the previously disclosed litigation filed in 2002 in the U.S. District Court in the Eastern District of Texas.
DaVita anticipates making repayments in the amount of $55 million plus attorneys fees as part of the settlement.
The government thoroughly investigated allegations raised by a sole individual regarding the company's Epogen practices over a 10 year period and the government never intervened or filed any claims against DaVita. However, the individual was able to pursue the claims on his own.
DaVita and its affiliated physicians did nothing wrong and stand by their anemia management practices, which were always consistent with their mission of
providing the best possible care for each individual patient. As a result, the agreement contains no finding of wrongdoing or admission of liability by DaVita or its affiliated physicians. Nonetheless, agreements such as this one are sometimes in the best interest of shareholders.
DaVita is a registered trademark of DaVita Inc. All other trademarks are the property of their respective owners.
